Joan E. Zweben, PhD CHAPTER35 CHAPTER OUTLINE ■ EPIDEMIOLOGY ■ MEDICAL CONSIDERATIONS ■ PSYCHIATRIC DISORDERS ■ SPECIAL POPULATIONS ■ ADDITIONAL TREATMENT ISSUES ■ CONCLUSIONS Gender disparities in the treatment of women were largely ignored until the…
The Hon. Peggy Fulton Hora, JD (Ret.) CHAPTER113 CHAPTER OUTLINE ■ DEFINITIONS ■ A NEW APPROACH TO AN OLD PROBLEM ■ WHY DRUG TREATMENT COURTS WORK ■ THE COURTS AND PHYSICIANS WORKING TOGETHER The…
Joseph J. Westermeyer, MD, MPH, PhDMarion Warwick, MD, MPH CHAPTER37 CHAPTER OUTLINE ■ DEFINITIONS RELATED TO SUBSTANCE USE AND ABUSE ■ CULTURE AND PATTERNS OF SUBSTANCE USE AND ABUSE ■ CULTURAL ASPECTS OF…
Robert L. Balster, PhD CHAPTER16 CHAPTER OUTLINE ■ DEFINITION ■ DRUGS IN THE CLASS ■ ABUSE OF INHALANTS ■ ABSORPTION AND METABOLISM ■ MECHANISMS OF ACTION ■ ADDICTION LIABILITY ■ TOXICITY/ADVERSE EFFECTS ■ FUTURE RESEARCH DIRECTIONS DEFINITION There…
Traci L. Brooks, MDJohn R. Knight, MD CHAPTER103 CHAPTER OUTLINE ■ SCREENING FOR USE ■ SCREENING FOR RISKS AND PROBLEMS ■ SCREEN-SPECIFIC STRATEGIES ■ SUBSTANCE USE SPECTRUM ■ FOLLOW-UP AND REFERRAL TO TREATMENT ■ SUMMARY Medical…
James O. Prochaska, PhD CHAPTER55 CHAPTER OUTLINE ■ THE STAGES OF CHANGE ■ USING THE STAGES OF CHANGE MODEL TO MOTIVATE PATIENTS ■ CONCLUSIONS What motivates people to take action? The answer to…
Robert L. DuPont, MD, FASAMBruce A. Goldberger, PhD, DABFTMark S. Gold, MD, FASAM CHAPTER112 CHAPTER OUTLINE ■ EVOLUTION OF DRUG TESTING ■ THE SCIENCE OF DRUG TESTING ■ ON-SITE VERSUS LABORATORY ANALYSIS ■ CHOICE…
Paul H. Earley, MD, FASAM CHAPTER41 CHAPTER OUTLINE ■ PREVALENCE ■ CHARACTERISTICS OF ADDICTED PHYSICIANS ■ DRUGS ABUSED ■ RISK FACTORS ■ ADDICTION COMORBIDITY ■ THEORIES OF ADDICTION AMONG PHYSICIANS ■ IDENTIFICATION, INTERVENTION, AND ASSESSMENT ■ TREATMENT ■ CONTROVERSIES…
